Gloria Elliott, Ph.D.

Stories

ARPA-H funds race to store cell therapies at room temperature

Overseeing the four-year BioStabilization Systems program

ARPA-H committed up to $87 million to a four-year program aiming to store living cell therapies at room temperature, ending the cold chain that defines modern biologics. CaseBioscience, a Colorado biopreservation firm, announced Oct. 2 that it joined one of three funded teams, led by Likarda, awarded up to $7.3 million.

Updated 1 hour ago

Notable Quotes

Many of the newest therapeutics on the market rely on very cold storage temperatures, which contribute to unacceptably ballooning price tags.

from ARPA-H funds race to store cell therapies at room temperature · Updated 1 hour ago

If we can eliminate the need for deep freezing, it will unlock the full, life-changing potential of cell-based therapies for patients who currently do not have access to them.

from ARPA-H funds race to store cell therapies at room temperature · Updated 1 hour ago